The ability to adhere to human intestinal mucus was tested for lactic acid bacteria of clinical blood culture, human fecal and dairy origin. The blood culture isolates were found to adhere better than the dairy strains. Of the Lactobacillus rhamnosus strains (nine clinical, 10 fecal and three dairy), blood culture isolates adhered better than the fecal strains. Although these results indicate a trend for blood culture isolates to bind to intestinal mucus in higher numbers than strains of dairy and human fecal origin, other factors are also likely to be involved in the etiology of lactobacillemia since some of the clinical Lactobacillus isolates exhibited a relatively low level of adhesion. ß
Introduction
Lactobacillus strains are generally regarded as safe due to their long history of safe use in fermented foods and, in many cases, their presence in the normal intestinal micro£ora of humans. However, Lactobacillus strains have been associated with some isolated cases of bacteremic infection in patients with immune suppression or underlying disease, such as endocarditis, meningitis, pneumonia and local suppurative conditions [1] . There has also been some speculation about a possible increase in Lactobacillus infections [2^4] . It is generally believed that lactobacilli involved in bacteremia originate from the patient's own gastrointestinal micro£ora [5] . When new potential probiotic strains are used, safety aspects must always be considered, as it is important to determine if the strain has any factors indicating virulence. The mechanism in opportunistic Lactobacillus infections is thus of great interest for determining the potential risk factors in probiotic lactobacilli.
The ability to adhere to the intestinal mucosa is considered one of the main selection criteria for potential probiotics [6] as it prolongs their persistence in the intestine [7] and thus allows the probiotic to exert its healthful e¡ects longer. However, adhesion is also considered a potential virulence factor for pathogenic bacteria [8] . The intestinal mucus is an important site for bacterial adhesion and colonization [9] and thus provides a good model for in vitro studies of the binding abilities of probiotics.
Our previous studies indicate that the ability to adhere well to human intestinal mucus tends to be common among lactobacilli from bacteremia in comparison to those of dairy origin [10, 11] . Our objective in this study was to evaluate whether the ability to bind in high numbers to mucus is a property promoting lactobacillar translocation and is as such a factor to consider when planning probiotic therapy. This is of particular concern in patients with underlying diseases predisposing to bacteremia. For this assessment, the ability to adhere to human intestinal mucus was determined for Lactobacillus, Bi¢dobacterium, Carnobacterium and Enterococcus strains, to determine whether strains of blood culture origin were able to bind in larger numbers to the intestinal mucus than the respective species of intestinal or dairy origin. This would indi-cate whether mucus adhesion is a general phenomenon among fecal lactobacilli or whether it is a factor in the potential translocation of a Lactobacillus strain.
Materials and methods
In the current study, 55 bacterial strains were tested for adhesion to intestinal mucus. Lactobacilli accounted for 48 of the strains. Sixteen of the strains were clinical blood culture isolates (Table 1) , most were obtained from patients with severe underlying diseases [12] . Twenty-¢ve of the strains tested were fecal isolates from healthy adult volunteers (Table 2) , and 14 strains were of dairy origin (Table 3 ). Of the remaining seven strains, ¢ve were bi¢do-bacteria (one clinical, three fecal, one dairy), one was a clinical Carnobacterium strain (Table 1 ) and one a dairy Enterococcus strain (Table 3 ). All strains were stored at 370³C in 40% glycerol and subcultured minimally to avoid changes in the properties of the strains due to continuous passage in laboratory media.
Isolation and identi¢cation of fecal strains
The three adult fecal Bi¢dobacterium isolates were kindly provided by Dr. F. He (Takanashi Milk Products Co., Ltd., Yokohama, Japan). Fecal samples were collected from healthy individuals (n = 28; age 41 þ 8.6 years), the subjects refrained from consuming fermented dairy products in order to avoid isolation of dairy lactobacilli. Serial dilutions were made in phosphate-bu¡ered saline (PBS; 10 mM phosphate, pH 7.2) and 50-Wl aliquots were plated onto de Man, Rogosa and Sharpe agar (MRS; Merck, Germany). The plates were incubated for 24^72 h at 37³C under anaerobic conditions. From each sample, 20 randomly picked colonies were subcultured on MRS agar. Further analysis involved Gram staining, catalase test and identi¢cation by API 50 CHL carbohydrate fermentation pattern (BioMërieux, Marcy-l'Etoile, France). Where identi¢cation was equivocal (doubtful or unacceptable identi¢cation) strains were identi¢ed by protein patterns as described by Henriksson and co-workers [13] . A similar number of human fecal isolates to clinical isolates were then chosen for further study. Where possible these strains were chosen from a range of subjects and were strains with unequivocal identi¢cation.
Culture conditions
All lactobacilli, the Carnobacterium and Enterococcus strains were cultured under anaerobic conditions for 172 0 h at 37³C in MRS broth containing 10 Wl ml 31 of tritiated thymidine (5P-3 H, 117 Ci mmol 31 ; Amersham International, UK) as radiolabel. The bi¢dobacteria were cultured in GAM broth (Nissui Seiyaku Co., Tokyo, Japan) for 24^36 h with the same radiolabel. 
Human intestinal mucus preparation
Mucus was isolated from feces by extraction and dual ethanol precipitation according to the method of Miller and Hoskins [14] , modi¢ed by Kirjavainen and co-workers [15] and Ouwehand and co-workers [11] . In short, fecal samples were collected from healthy adults (n = 17; age: 41 þ 8.6 years) and suspended in PBS containing protease inhibitors. The suspension was centrifuged to remove particulate matter. The mucus was then isolated from the clear extract by dual ethanol precipitation, lyophilized and ¢nally dissolved in HH at a concentration of 10 mg ml 31 , using an equal amount from each of the 17 mucus preparations, and stored at 370³C until use.
Adhesion assay
The in vitro adhesion assay was performed as described by Cohen and Laux [16] . Brie£y, 100 Wl of mucus was passively immobilized in microtiter plate wells (MaxiSorp1; Nunc, Denmark) by overnight incubation at 4³C. Any unbound mucus was removed by washing the wells twice with 250 Wl of HH, then 100 Wl of radioactively labeled bacteria was added to each well. After incubation at 37³C for 1 h, the wells were washed twice with HH and 200 Wl of 1% SDS in 0.1 M NaOH added to lyse and release the bacteria. The plate was further incubated at 60³C for 1 h and the contents of the wells quantitatively transferred to microfuge tubes containing scintillation liquid (OptiPhase`HiSafe 3'; Wallac, UK). Radioactivity was assessed by liquid scintillation and expressed as the percentage of radioactivity recovered from the wells compared to 100 Wl of the radiolabelled bacterial suspension.
Statistical analysis
The results of the adhesion experiments are presented as average with S.D. of three independent experiments, which were performed with four parallels. The Kruskal^Wallis test was used to evaluate the statistical signi¢cance (P 6 0.05) of variation in the adherence abilities between bacteria of di¡erent origin (i.e. blood, fecal or dairy). Differences in adhesion between the origin groups and species were analyzed with the Mann^Whitney U test.
Results

The normal human fecal Lactobacillus £ora
Lactobacilli were not cultured from seven of the 28 fecal samples (i.e. 6 2U10 2 lactobacilli g 31 feces). From the remaining samples, the most common Lactobacillus species isolated were L. rhamnosus (10/28 samples), L. paracasei (7/28 samples) and L. acidophilus (3/28). L. curvatus and L. plantarum were identi¢ed from two individuals and L. coprophilus, L. crispatus, L. delbrueckii subsp. lactis and Lc. lactis were identi¢ed from one sample only (but not the same sample). This indicates that L. rhamnosus is one of the most common Lactobacillus species in the intestine of the Finnish population.
Adhesion ability of strains from di¡erent sources
With the exception of L. rhamnosus GG (LGG), L. delbrueckii subsp. bulgaricus and L. acidophilus LA5 the human fecal isolates and the clinical strains tended to adhere better to intestinal mucus than the dairy strains (P = 0.098; Tables 1^3). The di¡erence in the ability of dairy and clinical strains to adhere to immobilized intestinal mucus was statistically signi¢cant (P = 0.014; Fig. 1 ). There is some overlap of the interquartile range of the clinical and dairy Lactobacillus strains. However, the median adhesion of the dairy strains is below the 10 percentile of the clinical strains.
Adhesion ability of L. rhamnosus strains from di¡erent origin
Despite the considerable overlap of the interquartile range of the clinical and fecal L. rhamnosus strains, the median of the fecal stains is less than the 10 percentile of the clinical strains, 2.40 and 3.06 respectively (Fig. 2) . The clinical L. rhamnosus strains were thus found to adhere signi¢cantly better than the human fecal strains (P 6 0.05). The clinical L. rhamnosus strains did not adhere better than the other clinical Lactobacillus strains (P s 0.05). As there were only three dairy (speci¢cally two dairy and one pharmaceutical) L. rhamnosus strains, statistical di¡erences could not be analyzed.
Discussion
Regardless of the nature of action that ingested bacteria have on the host, bacteria have a greater impact when able to adhere to the intestinal mucosal surface and thus maintain their presence in the gut longer. Mucus has a dual role in the management of the micro£ora. It can promote bacterial colonization by serving as an initial binding site, nutrient source and matrix on which the bacteria can proliferate [9] . Conversely, it can inhibit bacterial adhesion to the epithelium. During many enteric infections mucus secretion is extensive, with the result that the o¡ending microorganisms are dislodged from the mucosal surface and expelled from the intestinal tract. In this study, strains of clinical origin generally, especially L. rhamnosus, adhered in greater numbers to human intestinal mucus than the human fecal isolates and the dairy strains. This suggests that strong adhesion to mucus may be involved in mucosal translocation of lactobacilli in a host who is immune compromised or has a severe underlying disease. However, since also some low adhesive strains are present among the clinical isolates, it is likely that other factors than strong mucosal adhesion have been involved in the translocation of these lactobacilli from the intestine to the blood stream.
It has been speculated that L. rhamnosus is associated with infections more often than other lactobacilli [1] and that these strains are generally of intestinal origin [5] . In this study we showed that bacteremia isolates of L. rhamnosus strains adhered signi¢cantly better than fecal L. rhamnosus strains from healthy humans. This result correlates with our previous work where we tested the ability to adhere to intestinal mucus of eight of the clinical Lactobacillus isolates tested in this study [16] . We did not ¢nd, however, that the L. rhamnosus strains adhered better than other lactobacilli of clinical origin, so the ability to adhere strongly does not explain the greater number of infections caused by this species. However, L. rhamnosus was the most common Lactobacillus species isolated from the fecal samples. If it is one of the dominant Lactobacillus strains in the intestine in the studied population, then this may explain why it is more often involved in bacteremia cases than other lactobacilli. L. rhamnosus is also intrinsically resistant to vancomycin which is often used in antibiotic therapy of severe diseases.
In this study, the dairy strains LGG, L. delbrueckii subsp. bulgaricus (a normal yogurt strain) and L. acidophilus LA5 (a common strain in bio-yogurts) were among the most adhesive strains tested. It is likely that in a healthy gut, the ability to adhere may allow the probiotic to exert its healthful e¡ects, albeit transiently. In a diseased gut, the ability to adhere may increase the possibility of translocation when the body's defense mechanisms are impaired.
The long history of safe use of yogurt attests to the safety of L. delbrueckii subsp. bulgaricus. Also L. acidophilus LA5 has been in common use around the world for more than 20 years and has not been connected to clinical Table 3 Lactic acid bacteria of dairy origin and their adhesion to immobilized human intestinal mucus Bacterial strain Originisolates although its implication has not been evaluated. L. rhamnosus GG has been used in dairy products in Finland for 10 years, and only one clinical case with a strain indistinguishable from LGG has been reported [17] .
Although the results presented here indicate that high adhesion may play some role in the translocation of lactobacilli (and other genera) into the circulation, the results also indicate that other factors are likely to be involved in the development of the lactobacillemia since some of the clinical isolates tested exhibited a low level of adhesion. On the nature of these factors we can only speculate, though adhesion to extracellular matrix proteins, hemolytic activity, platelet aggregation and serum resistance are currently under investigation.
